These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 18698828)
1. Dual detection approach to a more accurate measure of relative purity in high-throughput characterization of compound collections. Lemoff A; Yan B J Comb Chem; 2008; 10(5):746-51. PubMed ID: 18698828 [TBL] [Abstract][Full Text] [Related]
2. Streamlined system for purifying and quantifying a diverse library of compounds and the effect of compound concentration measurements on the accurate interpretation of biological assay results. Popa-Burke IG; Issakova O; Arroway JD; Bernasconi P; Chen M; Coudurier L; Galasinski S; Jadhav AP; Janzen WP; Lagasca D; Liu D; Lewis RS; Mohney RP; Sepetov N; Sparkman DA; Hodge CN Anal Chem; 2004 Dec; 76(24):7278-87. PubMed ID: 15595870 [TBL] [Abstract][Full Text] [Related]
3. Quality control in combinatorial chemistry: determinations of amounts and comparison of the "purity" of LC-MS-purified samples by NMR, LC-UV and CLND. Letot E; Koch G; Falchetto R; Bovermann G; Oberer L; Roth HJ J Comb Chem; 2005; 7(3):364-71. PubMed ID: 15877465 [TBL] [Abstract][Full Text] [Related]
4. Quality control in combinatorial chemistry: determination of the quantity, purity, and quantitative purity of compounds in combinatorial libraries. Yan B; Fang L; Irving M; Zhang S; Boldi AM; Woolard F; Johnson CR; Kshirsagar T; Figliozzi GM; Krueger CA; Collins N J Comb Chem; 2003; 5(5):547-59. PubMed ID: 12959555 [TBL] [Abstract][Full Text] [Related]
5. Determination of relative response factors for chromatographic investigations using NMR spectrometry. Webster GK; Marsden I; Pommerening CA; Tyrakowski CM; Tobias B J Pharm Biomed Anal; 2009 Jul; 49(5):1261-5. PubMed ID: 19345032 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of an LC-UV method for the quantification and purity determination of the novel anticancer agent C1311 and its pharmaceutical dosage form. den Brok MW; Nuijen B; Hillebrand MJ; Grieshaber CK; Harvey MD; Beijnen JH J Pharm Biomed Anal; 2005 Sep; 39(1-2):46-53. PubMed ID: 15899571 [TBL] [Abstract][Full Text] [Related]
7. The use of differential scanning calorimetry for the purity verification of pharmaceutical reference standards. Mathkar S; Kumar S; Bystol A; Olawoore K; Min D; Markovich R; Rustum A J Pharm Biomed Anal; 2009 Apr; 49(3):627-31. PubMed ID: 19186017 [TBL] [Abstract][Full Text] [Related]
9. High-throughput characterization and quality control of small-molecule combinatorial libraries. Kenseth JR; Coldiron SJ Curr Opin Chem Biol; 2004 Aug; 8(4):418-23. PubMed ID: 15288253 [TBL] [Abstract][Full Text] [Related]
10. Parallel preparative high-performance liquid chromatography with on-line molecular mass characterization. Edwards C; Liu J; Smith TJ; Brooke D; Hunter DJ; Organ A; Coffey P Rapid Commun Mass Spectrom; 2003; 17(18):2027-33. PubMed ID: 12955730 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of an anion-exchange LC-UV method for the quantification and purity determination of the DNA plasmid pDERMATT. Quaak SG; Nuijen B; Haanen JB; Beijnen JH J Pharm Biomed Anal; 2009 Feb; 49(2):282-8. PubMed ID: 19111423 [TBL] [Abstract][Full Text] [Related]
12. High-throughput determination of identity, purity, and quantity of combinatorial library members using LC/MS/UV/ELSD. Fang L; Pan J; Yan B Biotechnol Bioeng; 2000-2001; 71(2):162-71. PubMed ID: 11288070 [TBL] [Abstract][Full Text] [Related]
13. One-minute full-gradient HPLC/UV/ELSD/MS analysis to support high-throughput parallel synthesis. Kyranos JN; Lee H; Goetzinger WK; Li LY J Comb Chem; 2004; 6(5):796-804. PubMed ID: 15360216 [TBL] [Abstract][Full Text] [Related]
14. Application of parallel gradient high performance liquid chromatography with ultra-violet, evaporative light scattering and electrospray mass spectrometric detection for the quantitative quality control of the compound file to support pharmaceutical discovery. Squibb AW; Taylor MR; Parnas BL; Williams G; Girdler R; Waghorn P; Wright AG; Pullen FS J Chromatogr A; 2008 May; 1189(1-2):101-8. PubMed ID: 18061198 [TBL] [Abstract][Full Text] [Related]
15. A strategy for high-throughput assay development using leads derived from nuclear magnetic resonance-based screening. Hajduk PJ; Betz SF; Mack J; Ruan X; Towne DL; Lerner CG; Beutel BA; Fesik SW J Biomol Screen; 2002 Oct; 7(5):429-32. PubMed ID: 14599358 [TBL] [Abstract][Full Text] [Related]
16. Purifying the masses: integrating prepurification quality control, high-throughput LC/MS purification, and compound plating to feed high-throughput screening. Isbell JJ; Zhou Y; Guintu C; Rynd M; Jiang S; Petrov D; Micklash K; Mainquist J; Ek J; Chang J; Weselak M; Backes BJ; Brailsford A; Shave D J Comb Chem; 2005; 7(2):210-7. PubMed ID: 15762748 [TBL] [Abstract][Full Text] [Related]
17. Quantitative and qualitative control of cytotoxic preparations by HPLC-UV in a centralized parenteral preparations unit. Delmas A; Gordien JB; Bernadou JM; Roudaut M; Gresser A; Malki L; Saux MC; Breilh D J Pharm Biomed Anal; 2009 Jul; 49(5):1213-20. PubMed ID: 19362442 [TBL] [Abstract][Full Text] [Related]
18. Comparison of HPLC, UV spectrophotometry and potentiometric titration methods for the determination of lumefantrine in pharmaceutical products. da Costa César I; Nogueira FH; Pianetti GA J Pharm Biomed Anal; 2008 Sep; 48(1):223-6. PubMed ID: 18571353 [TBL] [Abstract][Full Text] [Related]
19. Reliable assay of extreme enantiomeric purity values by a new circular dichroism based HPLC detection system. Bertucci C; Andrisano V; Cavrini V; Castiglioni E Chirality; 2000 Feb; 12(2):84-92. PubMed ID: 10637414 [TBL] [Abstract][Full Text] [Related]
20. Use of (1)H NMR to facilitate solubility measurement for drug discovery compounds. Lin M; Tesconi M; Tischler M Int J Pharm; 2009 Mar; 369(1-2):47-52. PubMed ID: 19073245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]